口服胰岛素。
Oral insulin.
机构信息
Bharti Hospital, Karnal, India.
出版信息
Diabetol Metab Syndr. 2010 Nov 8;2:66. doi: 10.1186/1758-5996-2-66.
Abstract
Oral insulin is an exciting area of research and development in the field of diabetology. This brief review covers the various approaches used in the development of oral insulin, and highlights some of the recent data related to novel oral insulin preparation.
摘要
口服胰岛素是糖尿病学领域令人兴奋的研究和开发领域。这篇简要综述涵盖了开发口服胰岛素中使用的各种方法，并重点介绍了一些与新型口服胰岛素制剂相关的最新数据。
相似文献
1
Oral insulin.口服胰岛素。
Diabetol Metab Syndr. 2010 Nov 8;2:66. doi: 10.1186/1758-5996-2-66.
2
[New trends in diabetology].[糖尿病学的新趋势]
Vnitr Lek. 2004 Oct;50 Suppl 1:S76-80.
3
Diabetology and Nanotechnology: A Compelling Combination.糖尿病学与纳米技术：引人注目的结合。
Recent Pat Nanotechnol. 2025;19(1):4-16. doi: 10.2174/0118722105253055231016155618.
4
Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.晚期2型糖尿病肾病心血管危险因素的管理：肾脏病学、糖尿病学和初级保健环境中的比较分析
J Hypertens. 2006 Aug;24(8):1655-61. doi: 10.1097/01.hjh.0000239303.93872.31.
5
6
New ways of insulin delivery.胰岛素递送的新方法。
Int J Clin Pract Suppl. 2011 Feb(170):31-46. doi: 10.1111/j.1742-1241.2010.02577.x.
7
Management of type-1 and type-2 diabetes by insulin injections in diabetology clinics - a scientific research review.糖尿病诊所中通过胰岛素注射治疗1型和2型糖尿病——一项科研综述
Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):148-70. doi: 10.2174/187221412800604608.
8
An overview of oral insulin delivery strategies (OIDS).口服胰岛素传递策略概述（OIDS）。
Int J Biol Macromol. 2022 May 31;208:565-585. doi: 10.1016/j.ijbiomac.2022.03.144. Epub 2022 Mar 26.
9
Oral insulin - a review of current status.口服胰岛素——现状综述。
Diabetes Obes Metab. 2010 Mar;12(3):179-85. doi: 10.1111/j.1463-1326.2009.01150.x.
10
A review on oral novel delivery systems of insulin through the novel delivery system formulations: A review.胰岛素经新型给药系统制剂的口服新型给药系统综述：一篇综述。
SAGE Open Med. 2024 Jan 18;12:20503121231225319. doi: 10.1177/20503121231225319. eCollection 2024.
引用本文的文献
1
Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus.2型糖尿病口服胰岛素给药系统的重要进展
J Nanobiotechnology. 2025 Jan 15;23(1):16. doi: 10.1186/s12951-024-03062-7.
2
Muco-Adhesive and Muco-Penetrative Formulations for the Oral Delivery of Insulin.用于胰岛素口服给药的粘膜粘附和粘膜穿透制剂。
ACS Omega. 2024 May 29;9(23):24121-24141. doi: 10.1021/acsomega.3c10305. eCollection 2024 Jun 11.
3
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.2型糖尿病的胰岛素治疗：临床疗效、患者报告结局及依从性挑战的见解
World J Diabetes. 2024 May 15;15(5):828-852. doi: 10.4239/wjd.v15.i5.828.
4
Pillararenes as Promising Carriers for Drug Delivery.多环芳烃作为有前途的药物传递载体。
Int J Mol Sci. 2023 Mar 8;24(6):5167. doi: 10.3390/ijms24065167.
5
Type 1 diabetes and engineering enhanced islet transplantation.1 型糖尿病与工程化胰岛移植。
Adv Drug Deliv Rev. 2022 Oct;189:114481. doi: 10.1016/j.addr.2022.114481. Epub 2022 Aug 21.
6
A Review: The Prospect of Inhaled Insulin Therapy via Vibrating Mesh Technology to Treat Diabetes.综述：振动网技术治疗糖尿病的吸入性胰岛素治疗的前景。
Int J Environ Res Public Health. 2020 Aug 10;17(16):5795. doi: 10.3390/ijerph17165795.
7
Chemically Precise Glycoengineering Improves Human Insulin.化学精准糖基工程改善人胰岛素。
ACS Chem Biol. 2018 Jan 19;13(1):73-81. doi: 10.1021/acschembio.7b00794. Epub 2017 Dec 1.
本文引用的文献
1
A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects.口服胰岛素（IN-105）在 2 型糖尿病患者进食状态下的剂量范围探索研究。
Diabetes Obes Metab. 2010 Aug;12(8):659-64. doi: 10.1111/j.1463-1326.2010.01213.x.
2
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes.口服胰岛素：与 2 型糖尿病患者皮下常规人胰岛素的比较。
Diabetes Care. 2010 Jun;33(6):1288-90. doi: 10.2337/dc09-1807. Epub 2010 Feb 25.
3
Oral insulin - a review of current status.口服胰岛素——现状综述。
Diabetes Obes Metab. 2010 Mar;12(3):179-85. doi: 10.1111/j.1463-1326.2009.01150.x.
4
Oral insulin and buccal insulin: a critical reappraisal.口服胰岛素与颊部胰岛素：批判性重新评估
J Diabetes Sci Technol. 2009 May 1;3(3):568-84. doi: 10.1177/193229680900300323.
5
The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes.口服胰岛素（Capsulin）在 2 型糖尿病患者等糖钳夹研究中的降血糖作用。
Diabetes Obes Metab. 2010 Jan;12(1):82-7. doi: 10.1111/j.1463-1326.2009.01146.x. Epub 2009 Sep 25.
6
Can insulin resistance be reversed by insulin therapy?胰岛素治疗能逆转胰岛素抵抗吗？
Med Hypotheses. 2009 Jan;72(1):34-5. doi: 10.1016/j.mehy.2008.07.050. Epub 2008 Sep 21.
7
beta-cell failure in diabetes and preservation by clinical treatment.糖尿病中的β细胞功能衰竭及临床治疗的保护作用。
Endocr Rev. 2007 Apr;28(2):187-218. doi: 10.1210/10.1210/er.2006-0038. Epub 2007 Mar 12.
8
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002.糖尿病护理流程及中间结果的改善：美国，1988 - 2002年
Ann Intern Med. 2006 Apr 4;144(7):465-74. doi: 10.7326/0003-4819-144-7-200604040-00005.
9
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.口服胰岛素对1型糖尿病患者亲属的影响：糖尿病预防试验——1型。
Diabetes Care. 2005 May;28(5):1068-76. doi: 10.2337/diacare.28.5.1068.
10
The physiological rationale for oral insulin administration.口服胰岛素给药的生理学原理。
Diabetes Technol Ther. 2004 Aug;6(4):510-7. doi: 10.1089/1520915041705929.
Zotero 插件